1-2 of 2
Shinsuke Iida
Close
Sort by
Journal Articles

A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial

Clinical Trials & Observations
Ken Ohmachi, Tomohiro Kinoshita, Kensei Tobinai, Gakuto Ogawa, Tomonori Mizutani, Nobuhiko Yamauchi, Noriko Fukuhara, Toshiki Uchida, Kazuhito Yamamoto, Kana Miyazaki, Norifumi Tsukamoto, Shinsuke Iida, Takahiko Utsumi, Isao Yoshida, Yoshitaka Imaizumi, Takashi Tokunaga, Shinichiro Yoshida, Yasufumi Masaki, Tohru Murayama, Yoshihiro Yakushijin, Youko Suehiro, Kisato Nosaka, Nobuaki Dobashi, Junya Kuroda, Yasushi Takamatsu, Dai Maruyama, Kiyoshi Ando, Kenichi Ishizawa, Michinori Ogura, Tadashi Yoshino, Tomomitsu Hotta, Kunihiro Tsukasaki, Hirokazu Nagai, the Japan Clinical Oncology Group
Journal: Blood Advances
Blood Adv (2021) 5 (4): 984–993.
https://doi.org/10.1182/bloodadvances.2020002567
Published: 2021
Includes: Supplemental data
Journal Articles

Robust CD8 + T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma

Masato Saito, Toshihiko Ishii, Itaru Urakawa, Asuka Matsumoto, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Susumu Suzuki, Takeshi Takahashi, Akimichi Morita, Hiroshi Inagaki, Shinsuke Iida, Takashi Ishida
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2180–2191.
https://doi.org/10.1182/bloodadvances.2020001641
Published: 2020
Includes: Supplemental data